China
GP profile: Samena Capital
Conservative yet contrarian, Samena Capital has carved its own path prioritizing patience, trust, and transparency. A younger generation of leadership is guiding entry into a new digital landscape
Asia technology: Anatomy of a rebound
Tech investment has been on a tear in Asia, with private equity joining venture capital at the party. While COVID-19 has contributed to these dynamics, the revival is rooted in deeper structural change
Chinese contact lens brand raises $65m
Dearer Medical, a Shanghai-based cosmetic contact lens manufacturer, has raised RMB420 million ($65 million) in Series B funding from CPE, Legend Capital, and Insight Capital.
Ince seeks $450 million for second China VC fund
Ince Capital is preparing to launch its second China venture capital fund with a target of $450 million, less than 18 months after closing its debut vehicle.
Buhuo Ventures completes renminbi fund restructuring
China’s Buhuo Ventures has closed its first US dollar-denominated fund at $100 million, following a GP-led cross-currency restructuring of a renminbi vehicle.
SIG leads $70m Series C for China's YiAuto
YiAuto, a Chinese new car marketplace, has raised a $70 million Series C round led by SIG. Existing investors GGV Capital, BlueRun Ventures, Sky9 Capital, and K2 Venture Partners also participated.
China AI chip designer Vastai raises $77m
Vastai Technologies, a China-based artificial intelligence (AI) chip designer, has raised RMB500 million ($77 million) in an extended Series A round led by Matrix Partners China and China Internet Investment Fund.
China's Mobvista acquires marketing business
Chinese digital marketing player Mobvista has acquired VC-backed local counterpart Reyun in a cash-and-stock transaction worth RMB1.5 billion ($232 million).
Trustar backs China beauty industry online services provider
Trustar Capital – formerly CITIC Capital Partners – has acquired a stake in Yifei Group, an online business service provider to China’s beauty and personal care industry, continuing its string of deals in this area over several years.
China Growth Capital leads Series C for Hygea Medical
China-based medical devices manufacturer Hygea Medical Technology has raised a RMB500 million ($77 million) Series C round led by China Growth Capital.
China agricultural drone company raises $30m
Chinese agricultural drone maker EAVision has raised $30 million in Series C funding led by Temasek Holdings, CITIC Agricultural Industry Fund, and Bits x Bites.
China bike-sharing player Hellobike pursues US IPO
Hello Inc, best known as the operator of China bike-sharing service Hellobike and backed by the likes of Alibaba's Ant Group and GGV Capital, has filed for an IPO in the US.
Deal focus: DCP, KKR milk new dairy opportunity
The private equity firms are backing Adopt A Cow’s combination of high-quality, high-transparency dairy products and its ability to reach young Chinese consumers through non-traditional channels
Deal focus: Xingyun's trade flow proposition
Having built its business on imports into China, e-commerce enabler Xingyun now wants to take Chinese brands global as well. For HI Transformational Fund, it represents a compelling inflection point
Deal focus: China big data player goes global
China’s Kyligence is plugging new technologies into an increasingly cloud-based and services-oriented enterprise software space. It has raised $70 million to pump up an international expansion
Q&A: B Capital's Raj Ganguly
In the past few months, B Capital Group has closed a late-stage fund, entered China, and moved forward with a seed-stage vehicle. Co-founder Raj Ganguly explains the firm’s thinking
Chinese COVID-19 vaccine developer Clover files for IPO
Clover Biopharmaceuticals, a Chinese pre-revenue drug developer that has raised $315 million across several funding rounds since 2011, has filed for a Hong Kong IPO.
Hong Kong e-commerce tracking start-up secures $66m
AfterShip, a Hong Kong-based e-commerce tracking service provider, has raised a $66 million Series B led by Tiger Global Management. GL Ventures also took part.
China data analytics start-up Kyligence raises $70m
Kyligence, a China-based data analytics business, has closed a $70 million Series D round led by SPDB International.
Loyal Valley leads Series B extension for China's Edigene
Loyal Valley Capital has led a RMB400 million ($62 million) Series B extension for EdiGene, a China-based biotech company that uses genome editing technologies to accelerate drug discovery.
Chinese funds back local AI-RPA player Laiye
Laiye Technology, a Chinese artificial intelligence (AI) start-up that specializes in robotic process automation (RPA) has raised $50 million in an extended Series C round led by Ping An Global Voyager Fund and Shanghai Artificial Intelligence Industry...
China's NextData raises $135m Series D
NextData, a China-based cybersecurity services provider, has secured $135 million in Series D funding led by CPE, Matrix China Partners, Hopu Investment, Tencent Holdings, and Xiang He Capital.
PE investors complete $4.6b China Biologic take-private
An investor group including Centurium Capital, CITIC Capital and Hillhouse Capital has completed its protracted pursuit of China Biologic Products Holdings with a $4.6 billion privatization.
